Journal
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA
Volume 28, Issue 4, Pages 833-849Publisher
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.iac.2008.07.001
Keywords
Intravenous immunoglobulin therapy; Subcutaneous immunoglobulin therapy; Primary immunodeficiency diseases
Categories
Funding
- NIAID NIH HHS [R01 AI065617, R01 AI065617-06A3] Funding Source: Medline
Ask authors/readers for more resources
The benefit of immunoglobulin (IG) replacement in primary antibody deficiencies is unquestionable. Many of these congenital disorders present early in life and this therapy is often first implemented in the young. This article focuses on the indications of IG replacement in children, with an emphasis on the specific diagnostic problems encountered in this population. Also presented is an overview of the practical aspects of IG administration in the pediatric setting, including the recognition and management of adverse reactions. Finally, the advent of subcutaneous IG, a therapeutic IG modality with the potential to have a great impact on the quality of life of children with antibody deficiencies and their families, is discussed.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available